Friday, September 30, 2016

Two new studies from the University of Iowa suggest that gene therapy may be a viable approach for treating or preventing lung disease caused by cystic fibrosis.

A principal investigator for one of the studies is Paul McCray, Jr., MD, professor of pediatrics and microbiology and graduate students; Ashley Cooney, Microbiology Program, and Ben Steines, Molecular and Cellular Biology Program are involved.

The research was funded in part by grants from National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Cystic Fibrosis Foundation and the National Institutes of Health (NIH). 

Read more about the study by following this link: Iowa Now article